ArticleJournal for immunotherapy of cancer2023

Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancer.

Julia Karbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.